Table 4 |
|||||||
|
PCNA and apoptosis indices and scores of β-catenin, COX-2, iNOS and nitrotyrosine expression in colonic adenocarcinomas. |
|||||||
|
Group |
Treatment |
PCNA-labeling |
Apoptotic |
Scores for: |
|||
|
|
|||||||
|
no. |
index (%) |
index (%) |
β-Catenin |
COX-2 |
iNOS |
Nitrotyrosine |
|
|
|
|||||||
|
1 |
AOM/DSS |
62.4 ± 13.7a (30) |
4.1 ± 1.9 (30) |
3.7 ± 0.7 (30) |
3.3 ± 0.7 (30) |
3.0 ± 1.0 (30) |
3.1 ± 0.8 (30) |
|
2 |
AOM/DSS/0.04% Nimesulide |
38.3 ± 11.1 b (6) |
11.8 ± 2.9 b (6) |
2.3 ± 1.0 c (6) |
1.3 ± 0.5 b (6) |
1.3 ± 0.5 b (6) |
1.7 ± 0.5 b (6) |
|
3 |
AOM/DSS/0.05% Troglitazone |
43.6 ± 9.0 b (9) |
10.0 ± 2.4 b (9) |
2.7 ± 0.7 c (9) |
1.8 ± 0.8 b (9) |
1.6 ± 0.5 b (9) |
1.8 ± 0.6 b (9) |
|
4 |
AOM/DSS/0.05% Bezafibrate |
40.5 ± 12.7 b (15) |
9.7 ± 2.7 b (15) |
3.0 ± 0.8 (15) |
1.8 ± 0.8 b (15) |
1.6 ± 0.6 b (15) |
2.2 ± 1.1 b (15) |
|
|
|||||||
|
Numbers in parentheses are numbers of lesions examined. a : means ± SD. b,c Significantly different from group 1 by Student's t-test (bP < 0.001 and cP < 0.05). |
|||||||
|
Kohno et al. BMC Cancer 2005 5:46 doi:10.1186/1471-2407-5-46 |
|||||||